Literature DB >> 15269927

Agreement between GPRD smoking data: a survey of general practitioners and a population-based survey.

James D Lewis1, Colleen Brensinger.   

Abstract

BACKGROUND: Cigarette smoking is a common habit that is associated with many diseases. Smoking is often an important confounding variable in pharmacoepidemiological studies. The General Practice Research Database (GPRD) is widely used in pharmacoepidemiological research. In this study, we compare data recorded in the GPRD with the smoking history obtained from direct query of general practitioners (GPs) and from a population-based survey.
METHODS: We completed a mailed survey of GPs caring for a random sample of 150 patients with inflammatory bowel disease. The survey asked the GP to categorize the patients smoking status on a specified date. These results were then compared to the data recorded in the GPRD. Smoking status of 225,308 randomly selected GPRD patients without inflammatory bowel disease was compared to the results of a population-based household survey.
RESULTS: Completed surveys with usable data were received from GPs on 136 of the 150 patients (91%). The sensitivity and positive predictive value of the database for current smoking were 78% (95% CI: 52-94) and 70% (95% CI: 46-88) respectively. The sensitivity and positive predictive value of former smoking were 53% (95% CI: 28-77) and 60% (95% CI: 32-84) respectively. Current and former smoking rates in the GPRD were 79% and 29% respectively of expected rates according to the population-based survey.
CONCLUSIONS: Current smoking is more completely recorded in the GPRD than former smoking. These data need to be considered when planning GPRD studies where smoking is an important exposure variable.

Entities:  

Mesh:

Year:  2004        PMID: 15269927     DOI: 10.1002/pds.902

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  28 in total

1.  Temporal and within practice variability in the health improvement network.

Authors:  Kevin Haynes; Warren B Bilker; Tom R Tenhave; Brian L Strom; James D Lewis
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-07-13       Impact factor: 2.890

2.  Confounding control in healthcare database research: challenges and potential approaches.

Authors:  M Alan Brookhart; Til Stürmer; Robert J Glynn; Jeremy Rassen; Sebastian Schneeweiss
Journal:  Med Care       Date:  2010-06       Impact factor: 2.983

3.  Validity of The Health Improvement Network (THIN) for epidemiologic studies of hepatitis C virus infection.

Authors:  Vincent Lo Re; Kevin Haynes; Kimberly A Forde; A Russell Localio; Rita Schinnar; James D Lewis
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-09       Impact factor: 2.890

Review 4.  Validity of diagnostic coding within the General Practice Research Database: a systematic review.

Authors:  Nada F Khan; Sian E Harrison; Peter W Rose
Journal:  Br J Gen Pract       Date:  2010-03       Impact factor: 5.386

5.  Capture of tobacco use among population-based registries: Findings from 10 National Program of Cancer Registries states.

Authors:  David A Siegel; S Jane Henley; Jennifer M Wike; A Blythe Ryerson; Christopher J Johnson; Judy R Rees; Lori A Pollack
Journal:  Cancer       Date:  2018-03-26       Impact factor: 6.860

Review 6.  Informatics and machine learning to define the phenotype.

Authors:  Anna Okula Basile; Marylyn DeRiggi Ritchie
Journal:  Expert Rev Mol Diagn       Date:  2018-02-16       Impact factor: 5.225

7.  Defining and measuring completeness of electronic health records for secondary use.

Authors:  Nicole G Weiskopf; George Hripcsak; Sushmita Swaminathan; Chunhua Weng
Journal:  J Biomed Inform       Date:  2013-06-29       Impact factor: 6.317

8.  Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study.

Authors:  Emilie M Gieling; Hendrika A van den Ham; Hein van Onzenoort; Jacqueline Bos; Cornelis Kramers; Anthonius de Boer; Frank de Vries; Andrea M Burden
Journal:  Br J Clin Pharmacol       Date:  2017-03-24       Impact factor: 4.335

9.  Testing bias in clinical databases: methodological considerations.

Authors:  Karin J Velthove; Hubert Gm Leufkens; Patrick C Souverein; René C Schweizer; Wouter W van Solinge
Journal:  Emerg Themes Epidemiol       Date:  2010-05-14

10.  The epidemiology of mortality after fracture in England: variation by age, sex, time, geographic location, and ethnicity.

Authors:  C Klop; T P van Staa; C Cooper; N C Harvey; F de Vries
Journal:  Osteoporos Int       Date:  2016-10-08       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.